| SAR millions | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 121.9 | 93.1 | 124.6 | 131.3 | 155.9 | +18.7% | |
| Cost of revenue | 85.4 | 74.7 | 90.3 | 92.9 | 114.2 | +22.9% | |
| Gross profit | 36.5 | 18.5 | 34.3 | 38.4 | 41.7 | +8.6% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 19.9 | 15.4 | 20.7 | 26.4 | 0.0 | −100.0% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 19.9 | 15.9 | 21.1 | 26.7 | 34.0 | +27.5% | |
| Operating income | 16.6 | 2.6 | 13.2 | 11.7 | 7.6 | −34.7% | |
| Interest expense | 0.6 | 3.7 | 7.2 | 7.8 | 0.0 | −100.0% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | 11.4 | 26.8 | (9.5) | (6.3) | (7.6) | −21.7% | |
| Pre-tax income | 28.0 | 29.4 | 3.7 | 5.4 | 0.0 | −100.0% | |
| Income tax | 0.5 | 1.0 | 0.9 | 1.1 | 0.0 | −100.0% | |
| Net income | 27.5 | 28.4 | 2.8 | 4.3 | (14.6) | −441.3% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | (14.6) | — | |
| EPS, basic (per share) | 5.98 | 6.18 | 0.69 | 1.07 | (2.92) | −372.9% | |
| EPS, diluted (per share) | 5.98 | 6.18 | 0.69 | 1.07 | (2.92) | −372.9% | |
| EBITDA | 30.1 | 34.1 | 13.1 | 15.1 | 7.6 | −49.4% | |
| Depreciation & amortization | 1.5 | 1.0 | 2.2 | 1.9 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 4,600,000 | 4,600,000 | 4,000,000 | 4,000,000 | 4,999,000 | +25.0% | |
| Weighted average diluted shares (shares) | 4,600,000 | 4,600,000 | 4,000,000 | 4,000,000 | 4,999,000 | +25.0% | |
| Gross margin | 29.9% | 19.8% | 27.5% | 29.2% | 26.7% | −2.5 pts | |
| Operating margin | 13.6% | 2.8% | 10.6% | 8.9% | 4.9% | −4.0 pts | |
| Net margin | 22.6% | 30.5% | 2.2% | 3.3% | −9.4% | −12.6 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
